Plasma sIL-2Rα levels are associated with disease progression in myelofibrosis with JAK2V617F but not CALR mutation-Reference-Cited by-同舟云学术

Plasma sIL-2Rα levels are associated with disease progression in myelofibrosis with JAK2V617F but not CALR mutation

Published:2020-03 Issue: Volume:90 Page:106319
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Barosi Giovanni^ORCID,Campanelli Rita,Catarsi Paolo,De Amici Mara,Abbà Carlotta,Viarengo Gianluca,Villani Laura,Gale Robert P.,Rosti Vittorio,Massa Margherita

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference20 articles.

1. Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?;Hasselbalch;Leuk. Res.,2013

2. B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: influence of ruxolitinib, interferon-α2, or combination treatment;Sørensen;Eur. J. Haematol.,2020

3. Impaired NK cell differentiate on of blood-derived CD34+ progenitors from patients with myeloid metaplasia with myelofibrosis;Briard;Clin. Immunol.,2003

4. Decreased natural killer (NK) activity in patients with myeloproliferative disorders;Froom;Cancer,1989

5. Reduced frequency of circulating CD4+CD25brightCD127lowFOXP3+ regulatory T cells in primary myelofibrosis;Massa;Blood,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functionally Relevant Cytokine/Receptor Axes in Myelofibrosis;Biomedicines;2023-09-05

2. Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis;Cancers;2022-04-01

3. New Markers of Disease Progression in Myelofibrosis;Cancers;2021-10-23

4. Clinical Relevance of VEGFA (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and Outcomes;Genes;2021-08-20

5. Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms;Frontiers in Immunology;2021-06-01